首页> 外文期刊>Cardiovascular Research >Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations.
【24h】

Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations.

机译:由desmocollin-2突变引起的致心律失常性右室心肌病的机制研究。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: Recent immunohistochemical studies observed the loss of plakoglobin (PG) from the intercalated disc (ID) as a hallmark of arrhythmogenic right ventricular cardiomyopathy (ARVC), suggesting a final common pathway for this disease. However, the underlying molecular processes are poorly understood. METHODS AND RESULTS: We have identified novel mutations in the desmosomal cadherin desmocollin 2 (DSC2 R203C, L229X, T275M, and G371fsX378). The two missense mutations (DSC2 R203C and T275M) have been functionally characterized, together with a previously reported frameshift variant (DSC2 A897fsX900), to examine their pathogenic potential towards PG's functions at the ID. The three mutant proteins were transiently expressed in various cellular systems and assayed for expression, processing, localization, and binding to other desmosomal components in comparison to wild-type DSC2a protein. The two missense mutations showed defects in proteolytic cleavage, a process which is required for the functional activation of mature cadherins. In both cases, this is thought to cause a reduction of functional DSC2 at the desmosomes in cardiac cells. In contrast, the frameshift variant was incorporated into cardiac desmosomes; however, it showed reduced binding to PG. CONCLUSION: Despite different modes of action, for all three variants, the reduced ability to provide a ligand for PG at the desmosomes was observed. This is in agreement with the reduced intensity of PG at these structures observed in ARVC patients.
机译:目的:最近的免疫组织化学研究观察到插层盘(ID)丢失了珠蛋白(PG),这是致心律失常性右心室心肌病(ARVC)的标志,表明该疾病的最终共同途径。然而,人们对潜在的分子过程了解甚少。方法和结果:我们已经鉴定出桥粒钙粘蛋白桥粒胶蛋白2(DSC2 R203C,L229X,T275M和G371fsX378)中的新突变。已对两个错义突变(DSC2 R203C和T275M)以及先前报道的移码变体(DSC2 A897fsX900)进行了功能表征,以检查其对ID处PG功能的致病潜力。与野生型DSC2a蛋白相比,这三种突变蛋白在各种细胞系统中瞬时表达,并进行了表达,加工,定位以及与其他桥粒成分的结合分析。这两个错义突变在蛋白水解切割中显示出缺陷,这是成熟钙粘蛋白功能激活所必需的过程。在两种情况下,都认为这会导致心肌细胞桥粒中功能性DSC2的减少。相比之下,移码变体被整合到心脏桥粒中。然而,它显示出与PG的结合减少。结论:尽管作用方式不同,但对于所有三个变体,在桥粒处观察到提供PG配体的能力均降低。这与在ARVC患者中观察到的在这些结构处PG的强度降低是一致的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号